{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:46:43Z","timestamp":1793908003862,"version":"4.8.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jns.2022.120327","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T20:29:33Z","timestamp":1655756973000},"page":"120327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review"],"prefix":"10.1016","volume":"439","author":[{"given":"Zahra","family":"Kolahchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MohammadHossein","family":"Khanmirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Mowla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120327_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-63761-3_1","article-title":"Introduction on coronavirus disease (COVID-19) pandemic: the global challenge","volume":"1318","author":"Rezaei","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jns.2022.120327_bb0010","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/978-3-030-63761-3_46","article-title":"COVID-19 and its global economic impact","volume":"1318","author":"Kolahchi","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0015","first-page":"323","article-title":"Stroke care during the COVID-19 pandemic; a global challenge","volume":"45","author":"Mowla","year":"2020","journal-title":"Iran J. Med. Sci."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0020","article-title":"Allergic reactions to current available COVID-19 vaccinations: pathophysiology, causality, and therapeutic considerations","volume":"9","author":"Kounis","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jns.2022.120327_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117607","article-title":"Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review","volume":"428","author":"Sharifian-Dorche","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.25594","article-title":"Factors associated with US adults\u2019 likelihood of accepting COVID-19 vaccination","volume":"3","author":"Kreps","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0035","article-title":"Influences on attitudes regarding potential COVID-19 vaccination in the United States","volume":"8","author":"Pogue","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jns.2022.120327_bb0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.toxrep.2021.04.003","article-title":"Safety of COVID-19 vaccines administered in the EU: should we be concerned?","volume":"8","author":"Hern\u00e1ndez","year":"2021","journal-title":"Toxicol. Rep."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0045","first-page":"1","article-title":"A review of adverse effects of COVID-19 vaccines","volume":"30","author":"Mushtaq","year":"2022","journal-title":"Infez Med."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.14740\/jnr698","article-title":"Simultaneous encephalitis and neuroretinitis after COVID-19 in a young adult: a case report","volume":"11","author":"Poursadeghfard","year":"2021","journal-title":"J. Neurol. Res."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0055","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1227\/neu.0000000000001902","article-title":"Characteristics of a COVID-19 cohort with large vessel occlusion: a multicenter international study","volume":"90","author":"Jabbour","year":"2022","journal-title":"Neurosurgery."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/jnnp-2021-328354","article-title":"Acute ischaemic stroke associated with SARS-CoV-2 infection in North America","volume":"93","author":"Dmytriw","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"14","key":"10.1016\/j.jns.2022.120327_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021046","article-title":"Age and acute ischemic stroke outcome in north American patients with COVID-19","volume":"10","author":"Dmytriw","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0070","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s12640-021-00389-z","article-title":"Comprehensive review on neuro-COVID-19 pathophysiology and clinical consequences","volume":"39","author":"Jafari Khaljiri","year":"2021","journal-title":"Neurotox. Res."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0075","doi-asserted-by":"crossref","first-page":"203","DOI":"10.14740\/jnr616","article-title":"COVID-19-related acute ischemic stroke in young adults: what is the optimal antithrombotic regimen for secondary prevention?","volume":"10","author":"Vahabizad","year":"2020","journal-title":"J. Neurol. Res."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/STROKEAHA.120.032927","article-title":"SARS-CoV-2 and stroke characteristics: a report from the multinational COVID-19 stroke study group","volume":"52","author":"Shahjouei","year":"2021","journal-title":"Stroke."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050931","article-title":"SARS-CoV-2 is a culprit for some, but not all acute ischemic strokes: a report from the multinational COVID-19 stroke study group","volume":"10","author":"Shahjouei","year":"2021","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0090","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1007\/s00415-021-10450-8","article-title":"Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review","volume":"268","author":"Ostovan","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2022.120327_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117183","article-title":"Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series","volume":"419","author":"Mowla","year":"2020","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2022.120327_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105353","article-title":"Unusual pattern of arterial macrothrombosis causing stroke in a young adult recovered from COVID-19","volume":"29","author":"Mowla","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117085","article-title":"Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic","volume":"417","author":"Sharifian-Dorche","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120327_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102939","article-title":"Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study","volume":"59","author":"Shahjouei","year":"2020","journal-title":"EBioMedicine."},{"issue":"12","key":"10.1016\/j.jns.2022.120327_bb0115","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/jnnp-2020-324653","article-title":"Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America","volume":"91","author":"Dmytriw","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120327_bb0120","doi-asserted-by":"crossref","first-page":"100256","DOI":"10.1016\/j.ensci.2020.100256","article-title":"Cerebral venous sinus thrombosis might be under-diagnosed in the COVID-19 era","volume":"20","author":"Shakibajahromi","year":"2020","journal-title":"eNeurologicalSci."},{"issue":"8","key":"10.1016\/j.jns.2022.120327_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941","article-title":"Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights","volume":"29","author":"Divani","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106440","article-title":"Stroke associated with COVID-19 vaccines","volume":"31","author":"Kakovan","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14740\/jnr700","article-title":"Cerebral coagulation complications following COVID-19 adenoviral vector vaccines: a systematic review","volume":"11","author":"Aghabaklou","year":"2021","journal-title":"J. Neurol. Res."},{"issue":"11","key":"10.1016\/j.jns.2022.120327_bb0140","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/jnnp-2021-326984","article-title":"Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"92","author":"Al-Mayhani","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0145","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s10072-021-05800-3","article-title":"Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report","volume":"43","author":"Mancuso","year":"2022","journal-title":"Neurol. Sci."},{"issue":"23","key":"10.1016\/j.jns.2022.120327_bb0150","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMoa2105385","article-title":"Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Scully","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3988\/jcn.2022.18.2.230","article-title":"Arterial embolic infarction after COVID-19 vaccination associated with antiplatelet factor 4 antibody","volume":"18","author":"Park","year":"2022","journal-title":"J Clin Neurol."},{"issue":"11","key":"10.1016\/j.jns.2022.120327_bb0160","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0165","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/vaccines10030349","article-title":"COVID-19 vaccine: between myth and truth","volume":"10","author":"Piccaluga","year":"2022","journal-title":"Vaccines."},{"issue":"10267","key":"10.1016\/j.jns.2022.120327_bb0170","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial","volume":"396","author":"Ramasamy","year":"2021","journal-title":"Lancet."},{"issue":"10269","key":"10.1016\/j.jns.2022.120327_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet."},{"issue":"10249","key":"10.1016\/j.jns.2022.120327_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet."},{"issue":"23","key":"10.1016\/j.jns.2022.120327_bb0185","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.jns.2022.120327_bb0190","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMc2105869","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination","volume":"384","author":"Muir","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/j.jns.2022.120327_bb0195","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMc2106075","article-title":"Thrombotic thrombocytopenia after Ad26.COV2.S vaccination \u2014 response from the manufacturer","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.jns.2022.120327_bb0200","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2021.7517","article-title":"US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, march 2 to April 21, 2021","volume":"325","author":"See","year":"2021","journal-title":"JAMA."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0205","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"27","key":"10.1016\/j.jns.2022.120327_bb0210","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jns.2022.120327_bb0220","author":"CDC"},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0225","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2940","article-title":"Incidence of cerebral venous thrombosis following SARS-CoV-2 infection vs mRNA SARS-CoV-2 vaccination in Singapore","volume":"5","author":"Tu","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.jns.2022.120327_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105906","article-title":"Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine","volume":"30","author":"Dias","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0235","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.7326\/L21-0244","article-title":"Thrombosis with thrombocytopenia after the messenger RNA-1273 vaccine","volume":"174","author":"Sangli","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jns.2022.120327_bb0240","article-title":"Case report: vaccine-induced immune thrombotic thrombocytopenia in a pancreatic Cancer patient after vaccination with messenger RNA\u22121273","volume":"8","author":"Su","year":"2021","journal-title":"Fron. Med."},{"key":"10.1016\/j.jns.2022.120327_bb0245","author":"Team VGCVT"},{"key":"10.1016\/j.jns.2022.120327_bb0250","author":"Team VGCVT"},{"key":"10.1016\/j.jns.2022.120327_bb0255","article-title":"Long term effectiveness of inactivated vaccine BBIBP-CorV (Vero Cells) against COVID-19 associated severe and critical hospitalization in Morocco","author":"Belayachi","year":"2022","journal-title":"medRxiv"},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0260","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cmi.2021.11.011","article-title":"Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study","volume":"28","author":"Vok\u00f3","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0265","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2107715","article-title":"Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile","volume":"385","author":"Jara","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120327_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2022.120327_bb0275","author":"(WHO) WHO"},{"key":"10.1016\/j.jns.2022.120327_bb0280","author":"(WHO) WHO"},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0285","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(20)30987-7","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial","volume":"21","author":"Wu","year":"2021","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0290","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(20)30831-8","article-title":"Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1\/2 trial","volume":"21","author":"Xia","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0295","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejim.2022.03.002","article-title":"Thrombotic events following Covid-19 vaccines compared to influenza vaccines","volume":"99","author":"Vallone","year":"2022","journal-title":"Eur. J. Int. Med."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0300","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1016\/j.radcr.2022.02.082","article-title":"Acute ischemic stroke after first dose of inactivated COVID-19 vaccine: a case report","volume":"17","author":"Elaidouni","year":"2022","journal-title":"Radiol Case Rep."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0305","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/1567202618666210927095613","article-title":"Acute Ischaemic stroke incidence after coronavirus vaccine in Indonesia: case series","volume":"18","author":"Hidayat","year":"2021","journal-title":"Curr. Neurovasc. Res."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106298","article-title":"First report of cerebral venous thrombosis following inactivated-virus Covid vaccination (Sinopharm and Sinovac)","volume":"31","author":"Hameed","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"22","key":"10.1016\/j.jns.2022.120327_bb0315","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120327_bb0320","author":"Barnes"},{"issue":"8","key":"10.1016\/j.jns.2022.120327_bb0325","first-page":"528","article-title":"Diagnosis of acute stroke","volume":"91","author":"Yew","year":"2015","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0330","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0040-1717078","article-title":"Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia","volume":"121","author":"Vayne","year":"2021","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jns.2022.120327_bb0335","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bbi.2021.04.006","article-title":"Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination \u2013 a report of two UK cases","volume":"95","author":"Mehta","year":"2021","journal-title":"Brain Behav. Immun."},{"issue":"23","key":"10.1016\/j.jns.2022.120327_bb0340","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jns.2022.120327_bb0345","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jns.2022.120327_bb0350","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jth.15352","article-title":"An observational study to identify the prevalence of thrombocytopenia and anti-PF4\/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination","volume":"19","author":"S\u00f8rvoll","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jns.2022.120327_bb0355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.thromres.2021.05.010","article-title":"Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination","volume":"203","author":"Douxfils","year":"2021","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0360","first-page":"355","article-title":"Addressing vaccine-induced immune thrombotic thrombocytopenia (VITT) following COVID-19 vaccination: a Mini-review of practical strategies","volume":"37","author":"Chen","year":"2021","journal-title":"Acta Cardiol. Sin."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0365","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9060559","article-title":"Thrombotic thrombocytopenia after COVID-19 vaccination: in search of the underlying mechanism","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.jns.2022.120327_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102662","article-title":"Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection","volume":"121","author":"McGonagle","year":"2021","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0375","article-title":"SARS-CoV-2 mRNA vaccines: immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jns.2022.120327_bb0380","doi-asserted-by":"crossref","first-page":"135564","DOI":"10.1016\/j.neulet.2020.135564","article-title":"Stroke in patients with COVID-19: clinical and neuroimaging characteristics","volume":"743","author":"Vogrig","year":"2021","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0385","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13195-020-00640-3","article-title":"Immediate and long-term consequences of COVID-19 infections for the development of neurological disease","volume":"12","author":"Heneka","year":"2020","journal-title":"Alzheimers Res. Ther."},{"issue":"10229","key":"10.1016\/j.jns.2022.120327_bb0390","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2022.120327_bb0395","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.647378","article-title":"Microglia fighting for neurological and mental health: on the central nervous system frontline of COVID-19 pandemic","volume":"15","author":"Gon\u00e7alves de Andrade","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jns.2022.120327_bb0400","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/NDT.S343438","article-title":"Post COVID-19 vaccination-associated neurological complications","volume":"18","author":"Assiri","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0405","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/ane.13608","article-title":"Stroke after COVID-19 vaccination","volume":"145","author":"Famularo","year":"2022","journal-title":"Acta Neurol. Scand."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0410","first-page":"451","article-title":"Diagnostic and treatment recommendations from the FACME ad-hoc expert working group on the management of cerebral venous sinus thrombosis associated with COVID-19 vaccination","volume":"36","year":"2021","journal-title":"Neurologia."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0415","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/jth.15341","article-title":"Recommendations for the clinical and laboratory diagnosis of VITT against COVID-19: communication from the ISTH SSC subcommittee on platelet immunology","volume":"19","author":"Nazy","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jns.2022.120327_bb0420","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/STROKEAHA.121.035564","article-title":"Diagnosis and management of cerebral venous sinus thrombosis with vaccine-induced immune thrombotic thrombocytopenia","volume":"52","author":"Furie","year":"2021","journal-title":"Stroke"},{"issue":"24","key":"10.1016\/j.jns.2022.120327_bb0425","doi-asserted-by":"crossref","first-page":"E913","DOI":"10.1503\/cmaj.210882","article-title":"Recognizing, managing and reporting vaccine-induced immune thrombotic thrombocytopenia","volume":"193","author":"Sholzberg","year":"2021","journal-title":"Can. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0430","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/1358863X19898253","article-title":"Heparin-induced thrombocytopenia (HIT): review of incidence, diagnosis, and management","volume":"25","author":"Hogan","year":"2020","journal-title":"Vasc. Med."},{"key":"10.1016\/j.jns.2022.120327_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2021.100101","article-title":"Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story","volume":"11","author":"Tsilingiris","year":"2021","journal-title":"Metabol Open."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0440","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1182\/blood.2021012152","article-title":"Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know","volume":"138","author":"Arepally","year":"2021","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.jns.2022.120327_bb0445","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJMc2109465","article-title":"Therapeutic plasma exchange in vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Patriquin","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0450","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00956-2021","article-title":"Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase","volume":"58","author":"Smadja","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0455","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0460","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ane.13512","article-title":"Thrombolysis for stroke in elderly in the late window period","volume":"144","author":"Mowla","year":"2021","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jns.2022.120327_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117451","article-title":"Safety and efficacy of antiplatelet use before intravenous thrombolysis for acute ischemic stroke","volume":"425","author":"Mowla","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105678","article-title":"Safety of intravenous thrombolysis for acute ischemic stroke in patients taking warfarin with subtherapeutic INR","volume":"30","author":"Mowla","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117265","article-title":"Laboratory factors associated with symptomatic hemorrhagic conversion of acute stroke after systemic thrombolysis","volume":"420","author":"Kamal","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"5","key":"10.1016\/j.jns.2022.120327_bb0480","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000510095","article-title":"Statins use and outcome of acute ischemic stroke patients after systemic thrombolysis","volume":"49","author":"Mowla","year":"2020","journal-title":"Cerebrovasc. Dis."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0485","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/STROKEAHA.119.026426","article-title":"Safety of intravenous thrombolysis among patients taking direct Oral anticoagulants: a systematic review and Meta-analysis","volume":"51","author":"Shahjouei","year":"2020","journal-title":"Stroke."},{"issue":"7","key":"10.1016\/j.jns.2022.120327_bb0490","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.03.021","article-title":"Intravenous thrombolysis for acute ischemic stroke in patients with thrombocytopenia","volume":"26","author":"Mowla","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"5\u20136","key":"10.1016\/j.jns.2022.120327_bb0495","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000439141","article-title":"Prior asymptomatic parenchymal hemorrhage does not increase the risk for intracranial hemorrhage after intravenous thrombolysis","volume":"40","author":"AbdelRazek","year":"2015","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0500","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/ijs.12616","article-title":"Is acute reperfusion therapy safe in acute ischemic stroke patients who harbor unruptured intracranial aneurysm?","volume":"10","author":"Mowla","year":"2015","journal-title":"Int. J. Stroke"},{"issue":"1\u20132","key":"10.1016\/j.jns.2022.120327_bb0505","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jns.2015.09.020","article-title":"Recurrent ischemic stroke can happen in stroke patients very early after intravenous thrombolysis","volume":"358","author":"Kamal","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.jns.2022.120327_bb0510","doi-asserted-by":"crossref","first-page":"E29","DOI":"10.1111\/ijs.12455","article-title":"Safety of intravenous thrombolysis for acute ischemic stroke in patients with preexisting intracranial neoplasms: a case series","volume":"10","author":"Singh","year":"2015","journal-title":"Int. J. Stroke"},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0515","article-title":"Successful intravenous thrombolysis for acute stroke caused by polycythemia vera","volume":"4","author":"Mowla","year":"2017","journal-title":"Arch. Neurosci."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0520","doi-asserted-by":"crossref","DOI":"10.14740\/jnr599","article-title":"Rate, clinical features, safety profile and outcome of intravenous thrombolysis for acute ischemic stroke in patients with negative brain imaging","volume":"10","author":"Mowla","year":"2020","journal-title":"J. Neurol. Res."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0525","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1017\/cjn.2020.138","article-title":"The clinical conundrum of managing ischemic stroke in patients with immune thrombocytopenia","volume":"48","author":"Alrohimi","year":"2021","journal-title":"Can. J. Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0530","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000339675","article-title":"Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions","volume":"34","author":"Seet","year":"2012","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0535","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jns.2017.03.003","article-title":"Delays in door-to-needle time for acute ischemic stroke in the emergency department: a comprehensive stroke center experience","volume":"376","author":"Mowla","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2022.120327_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106072","article-title":"Treatment of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia related acute ischemic stroke","volume":"30","author":"Kenda","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2022.120327_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117618","article-title":"Hyperdense middle cerebral artery sign and response to combination of mechanical Thrombectomy plus intravenous thrombolysis in acute stroke patients","volume":"429","author":"Mowla","year":"2021","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0550","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1038\/s41467-021-25010-x","article-title":"Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia","volume":"12","author":"De Michele","year":"2021","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.jns.2022.120327_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105942","article-title":"Acute ischemic stroke revealing ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia: impact on recanalization strategy","volume":"30","author":"Costentin","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.diii.2021.04.005","article-title":"Imaging of Oxford\/AstraZeneca\u00ae COVID-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"102","author":"Garnier","year":"2021","journal-title":"Diagn Interv Imaging."},{"key":"10.1016\/j.jns.2022.120327_bb0565","first-page":"1","article-title":"Ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia following COVID-19 vaccine: a case report with systematic review of the literature","author":"Cascio Rizzo","year":"2022","journal-title":"Cerebrovasc. Dis. (Basel, Switzerland)"},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0570","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15537\/smj.2021.42.10.20210326","article-title":"Ischemic stroke after AstraZeneca (Covid-19) vaccination","volume":"42","author":"Alammar","year":"2021","journal-title":"Saudi Med. J."},{"issue":"10285","key":"10.1016\/j.jns.2022.120327_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(21)00872-2","article-title":"Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"397","author":"Bayas","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2022.120327_bb0580","first-page":"6804456","article-title":"Widespread arterial thrombosis after ChAdOx1 nCov-19 vaccination","volume":"2022","author":"Berlot","year":"2022","journal-title":"Case Rep. Crit. Care"},{"issue":"7","key":"10.1016\/j.jns.2022.120327_bb0585","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/jth.15347","article-title":"Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine","volume":"19","author":"Blauenfeldt","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0590","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s13256-021-03083-y","article-title":"Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report","volume":"15","author":"Ceschia","year":"2021","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jns.2022.120327_bb0595","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clinimag.2021.08.021","article-title":"Neurological symptoms and neuroimaging alterations related with COVID-19 vaccine: cause or coincidence?","volume":"80","author":"Corr\u00eaa","year":"2021","journal-title":"Clin. Imaging"},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0600","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7861\/clinmed.2021-0321","article-title":"Arterial and venous thrombotic stroke after ChAdOx1 nCoV-19 vaccine","volume":"22","author":"Wills","year":"2022","journal-title":"Clin. Med. (Lond)."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0605","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1182\/blood.2021011958","article-title":"Prothrombotic immune thrombocytopenia after COVID-19 vaccination","volume":"138","author":"Tiede","year":"2021","journal-title":"Blood."},{"issue":"15","key":"10.1016\/j.jns.2022.120327_bb0610","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1212\/WNL.0000000000012576","article-title":"Adenovirus-vectored COVID-19 vaccine-induced immune thrombosis of carotid artery: a case report","volume":"97","author":"Walter","year":"2021","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.jns.2022.120327_bb0615","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4103\/aian.aian_541_21","article-title":"Neurological disorders seen during second wave of SARS-CoV-2 pandemic from two tertiary care centers in central and southern Kerala","volume":"24","author":"George","year":"2021","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2022.120327_bb0620","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-245445","article-title":"Cerebral arterial and venous thrombosis due to COVID-19 vaccine-induced immune thrombotic thrombocytopenia","volume":"15","author":"Pang","year":"2022","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.jns.2022.120327_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11040285","article-title":"A rare case of cerebral venous thrombosis and disseminated intravascular coagulation temporally associated to the COVID-19 vaccine administration","volume":"11","author":"D\u2019Agostino","year":"2021","journal-title":"J Pers Med."},{"issue":"8","key":"10.1016\/j.jns.2022.120327_bb0630","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jns.2022.120327_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106113","article-title":"Vaccine-induced immune thrombotic thrombocytopenia with concurrent arterial and venous thrombi following Ad26.COV2.S vaccination","volume":"30","author":"Charidimou","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"10.1016\/j.jns.2022.120327_bb0640","article-title":"Bilateral thalamic stroke: a case of COVID-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) or a coincidence due to underlying risk factors?","volume":"13","author":"Giovane","year":"2021","journal-title":"Cureus."},{"issue":"2","key":"10.1016\/j.jns.2022.120327_bb0645","doi-asserted-by":"crossref","first-page":"106233","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106233","article-title":"Repeated cardioembolic stroke after COVID-19 mRNA vaccination: a case report","volume":"31","author":"Yoshida","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:01:10Z","timestamp":1758384070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":129,"alternative-id":["S0022510X22001897"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120327","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccination; a systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120327"}}